Literature DB >> 12691937

Fetal tissue engineering from amniotic fluid.

Amir Kaviani1, Kristine Guleserian, Tjörvi E Perry, Russell W Jennings, Moritz M Ziegler, Dario O Fauza.   

Abstract

BACKGROUND: We have recently shown, in an animal model, that amniotic fluid can be a source of cells for fetal tissue engineering. This study was aimed at determining whether fetal tissue constructs could also be engineered from cells normally found in human amniotic fluid. STUDY
DESIGN: Cells obtained from the amniotic fluid of pregnant women at 15 to 19 weeks of gestation (n=6) were cultured in Dulbecco's Modified Eagle's medium (Sigma Chemical, St Louis, MO) containing 20% fetal bovine serum and 5 ng/mL basic fibroblast growth factor in a 95% humidified, 5% CO(2) chamber at 37 degrees C. A subpopulation of morphologically distinct cells was then mechanically isolated from the rest and selectively expanded. The lineage of this subpopulation of amniocytes was determined by immunofluorescent staining with antibodies against standard intermediate filaments and surface antigens. Cell proliferation rates were determined by oxidation assay. After cell expansion, colonies of amniocytes were statically and dynamically seeded onto both unwoven, 1-mm-thick polyglycolic acid polymer scaffold and acellular human dermis for 72 hours. The resulting constructs were analyzed by scanning electron microscopy.
RESULTS: Amniocytes stained positively for smooth muscle actin, vimentin, cytokeratin 18, and fibroblast surface protein, and negatively for desmin, cluster of differentiation 31, and von Willebrand's factor (Dako, Carpenteria, CA). These findings are consistent with a mesenchymal, fibroblast-myofibroblast cell lineage. Mesenchymal amniocytes could be rapidly expanded in culture, based on results of the proliferation assay. Scanning electron microscopy of amniocyte constructs revealed dense, confluent layers of cells surrounding the polymer matrices and firm cell adhesion to both PGA and Alloderm (Lifecell Corp, Branchburg, NJ) scaffolds. No evidence of cell death was observed.
CONCLUSIONS: Subpopulations of fetal mesenchymal cells can be consistently isolated from human amniotic fluid and rapidly expanded in vitro. Human mesenchymal amniocytes attach firmly to both polyglycolic acid polymer and acellular human dermis. The amniotic fluid can be a valuable and practical cell source for fetal tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691937     DOI: 10.1016/s1072-7515(02)01834-3

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  21 in total

1.  Schwann-like cells can be induction from human nestin-positive amniotic fluid mesenchymal stem cells.

Authors:  Tai-Mao Jiang; Zhi-Jun Yang; Chui-Ze Kong; Hong-Tian Zhang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-07-22       Impact factor: 2.416

Review 2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

3.  Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol.

Authors:  Shaun A Steigman; Myriam Armant; Lucy Bayer-Zwirello; Grace S Kao; Leslie Silberstein; Jerome Ritz; Dario O Fauza
Journal:  J Pediatr Surg       Date:  2008-06       Impact factor: 2.545

4.  Liver position is a prenatal predictive factor of prosthetic repair in congenital diaphragmatic hernia.

Authors:  Shaun M Kunisaki; Carol E Barnewolt; Judy A Estroff; Luanne P Nemes; Russell W Jennings; Jay M Wilson; Dario O Fauza
Journal:  Fetal Diagn Ther       Date:  2008-04-14       Impact factor: 2.587

Review 5.  Fetal endothelial and mesenchymal progenitors from the human term placenta: potency and clinical potential.

Authors:  Abbas Shafiee; Nicholas M Fisk; Dietmar W Hutmacher; Kiarash Khosrotehrani; Jatin Patel
Journal:  Stem Cells Transl Med       Date:  2015-03-13       Impact factor: 6.940

6.  The amniotic fluid-derived cells: the biomedical challenge for the third millennium.

Authors:  Giuseppe Simoni; Renato Colognato
Journal:  J Prenat Med       Date:  2009-07

7.  Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells.

Authors:  Guihua Jiang; Todd J Herron; Julie Di Bernardo; Kendal A Walker; K Sue O'Shea; Shaun M Kunisaki
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

Review 8.  Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.

Authors:  Jennifer Petsche Connell; Gulden Camci-Unal; Ali Khademhosseini; Jeffrey G Jacot
Journal:  Tissue Eng Part B Rev       Date:  2013-03-14       Impact factor: 6.389

Review 9.  Congenital anomalies: treatment options based on amniotic fluid-derived stem cells.

Authors:  Shaun M Kunisaki
Journal:  Organogenesis       Date:  2012-07-01       Impact factor: 2.500

10.  Isolation of osteogenic progenitors from human amniotic fluid using a single step culture protocol.

Authors:  Ivana Antonucci; Irene Iezzi; Elisena Morizio; Filiberto Mastrangelo; Andrea Pantalone; Monica Mattioli-Belmonte; Antonio Gigante; Vincenzo Salini; Giuseppe Calabrese; Stefano Tetè; Giandomenico Palka; Liborio Stuppia
Journal:  BMC Biotechnol       Date:  2009-02-16       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.